latest news releases from the newsroom
General Payment Systems, Inc.
Continental Prison Systems to Attend Texas Sheriff Association Conference
FRESNO, Calif., July 8, 2008 (PRIME NEWSWIRE) -- Continental Prison Systems, Inc. (Pink Sheets:CPSZ): a leader in Prison kiosk technology to streamline the inmate release process and a growing provider of the cost reducing process for loading funds onto an inmate's account over the internet or through a kiosk announced today that the EZ Kiosk and EZ Card divisions of Continental Prison Systems, Inc. will attend the Texas Sheriff Association (TSA) Conference show in San Antonio, July 19th-21st.
Hemispherx Biopharma, Inc.
Hemispherx Biopharma's Ampligen NDA for Chronic Fatigue Syndrome Accepted for Review by the FDA
PHILADELPHIA, July 8, 2008 (PRIME NEWSWIRE) -- Hemispherx Biopharma, Inc. (AMEX:HEB) today reported that the U.S. Food and Drug Administration (FDA) has accepted for review the Company's New Drug Application (NDA) for Ampligen(r), an experimental therapeutic, to treat Chronic Fatigue Syndrome (CFS), originally submitted in October 2007. Hemispherx is seeking marketing approval for the first-ever treatment for CFS. At present, only supportive, symptom-based care is available for CFS patients. The NDA for Ampligen(r), whose chemical designation is poly I : poly C12U, is also the first ever accepted for review by the FDA for systemic use of a toll-like receptor (TLR) therapy to treat any condition.
Cardio Infrared Technologies, Inc.
Cardio Infrared Technologies to Raise Up to $2M in Equity Funding
LAS VEGAS, July 8, 2008 (PRIME NEWSWIRE) -- Cardio Infrared Technologies, Inc. (Pink Sheets:CIRT), a leading Health and Wellness technology and marketing company, announced today that Cardio-Cor will begin selling a Private offering in the European Union beginning in August. Several European firms have expressed interest in selling the stock. The equity raise will be in concert with a Private offering in the US. Cardio-Cor expects to raise $2 million in equity during this concerted fund raising effort.
Austin Lighthouse Selects Manhattan Associates to Optimize Warehouse Management
ATLANTA, July 8, 2008 (PRIME NEWSWIRE) -- Global supply chain optimization provider Manhattan Associates, Inc. (Nasdaq:MANH) today announced that third-party logistics (3PL) provider Travis Association for the Blind, also known as Austin Lighthouse, has selected Manhattan's Billing Management, Slotting Optimization and Manhattan ILS: Integrated Logistics Solutions, built on Microsoft(r). NET.
Generex Biotechnology Corp.
Generex Provides Update On Dosing of Patients in Phase III Trial of Generex Oral-lyn
WORCESTER, Mass., July 8, 2008 (PRIME NEWSWIRE) -- Generex Biotechnology Corporation (Nasdaq:GNBT) (www.generex.com), the leader in drug delivery for metabolic diseases through the inner lining of the mouth, has initiated dosing of over one hundred patients in the Company's pivotal Phase III clinical trial of Generex Oral-lyn(tm), its flagship proprietary oral insulin spray product. Dosing of patients is now underway at 31 clinical trial sites in the United States, Canada, Russia, and Ukraine.